potential treatments for drug-resistant ailments. In 2013, Verdine became full-time CEO of Warp Drive Bio, then handed the CEO position to Lawrence Reid in 2016 in order to found two new startups, FogPharma and LifeMine. Wave Life Sciences Verdine is the Chairman of the Board of Wave Life Sciences, which uses synthetic chemistry to develop nucleic acid therapeutic candidates. Venture Capital Verdine has worked in the venture capital industry as a Venture Partner with Apple Tree Partners, Third Rock Ventures, and WuXi Healthcare Ventures, and as a Special Advisor to Texas Pacific Group. Scientific Consultation Verdine is a member of both the Board of Scientific Consultants of the Memorial Sloan-Kettering Cancer Center, the Board of Scientific Advisors of the National Cancer Institute, Advisory Board at Spinal Muscular Atrophy Foundation, and the Board of Reviewers at Bill & Melinda Gates Foundation. Recent Recognition 2019 - Honorary Doctor of Science Degree, Clarkson University 2019 - Herman S. Bloch Award for Scientific Excellence in Industry, University of Chicago 2011 - American Association for Cancer Research Award for Excellence in Chemistry in Cancer Research 2007 - Nobel Laureate Signature Award for Graduate Education in Chemistry, with Anirban Banerjee 2005 - Royal Society of Chemistry Nucleic Acid Award Lecture, Responses to DNA Damage conference References 1959 births Living people 21st-century American chemists Harvard Medical School faculty People from Somers Point, New Jersey Saint Joseph's University alumni Columbia Graduate School of Arts and Sciences alumni